1. Activation of 5-HT 2A Receptors Restores KCC2 Function and Reduces Neuropathic Pain after Spinal Cord Injury.
- Author
-
Sánchez-Brualla I, Boulenguez P, Brocard C, Liabeuf S, Viallat-Lieutaud A, Navarro X, Udina E, and Brocard F
- Subjects
- Acetates pharmacology, Animals, Female, Indenes pharmacology, Neuralgia complications, Peripheral Nerve Injuries complications, Rats, Serotonin 5-HT2 Receptor Agonists pharmacology, Spinal Cord Dorsal Horn metabolism, Spinal Cord Injuries complications, Symporters antagonists & inhibitors, Up-Regulation drug effects, K Cl- Cotransporters, Bridged Bicyclo Compounds pharmacology, Hyperalgesia prevention & control, Methylamines pharmacology, Neuralgia metabolism, Neuralgia prevention & control, Peripheral Nerve Injuries metabolism, Receptor, Serotonin, 5-HT2A metabolism, Spinal Cord Injuries metabolism, Symporters metabolism
- Abstract
Downregulation of the potassium chloride cotransporter type 2 (KCC2) after a spinal cord injury (SCI) disinhibits motoneurons and dorsal horn interneurons causing spasticity and neuropathic pain, respectively. We showed recently (Bos et al., 2013) that specific activation of 5-HT
2A receptors by TCB-2 [(4-bromo-3,6-dimethoxybenzocyclobuten-1-yl)methylamine hydrobromide] upregulates KCC2 function, restores motoneuronal inhibition and reduces SCI-induced spasticity. Here, we tested the potential analgesic effect of TCB-2 on central (thoracic hemisection) and peripheral [spared nerve injury (SNI)] neuropathic pain. We found mechanical and thermal hyperalgesia reduced by an acute administration of TCB-2 in rats with SCI. This analgesic effect was associated with an increase in dorsal horn membrane KCC2 expression and was prevented by pharmacological blockade of KCC2 with an intrathecal injection of DIOA [(dihydroindenyl)oxy]alkanoic acid]. In contrast, the SNI-induced neuropathic pain was not attenuated by TCB-2 although there was a slight increase of membrane KCC2 expression in the dorsal horn ipsilateral to the lesion. Up-regulation of KCC2 function by targeting 5-HT2A receptors, therefore, has therapeutic potential in the treatment of neuropathic pain induced by SCI but not by SNI., (Copyright © 2017 IBRO. Published by Elsevier Ltd. All rights reserved.)- Published
- 2018
- Full Text
- View/download PDF